#EAU20 Virtual - Challenges across the spectrum of bladder cancer

EAU
7/18/20, 12:00 PM
Europe/Madrid GMT+2

Description

Challenges across the spectrum of bladder cancer

Plenary session 03

 

Sat 18 July

09:05 - 11:25

Location:Virtual room 2Chairs: J.W.F. Catto, Sheffield (GB)

M. Rouprêt, Paris (FR)

A. Stenzl, Tübingen (DE)

 

Learning objectives

Clinical decision making for non muscle-invasive bladder cancer and new tools for adjuvant treatment for these tumours take a large part of this session. Furthermore an optimisation in the selection of elderly patients with advanced bladder cancer for surgical vs. conservative treatment will be presented. One part of the session deals with personalised treatment and its underlying genetic testing in bladder cancer.

 

09:05 - 09:15

Definition of very high-risk and refractory NMIBC

M. Babjuk, Prague (CZ)

09:15 - 09:45

Early cystectomy in high-risk NMIBC: A standard?

09:15 - 09:25

Pro

S. Shariat, Vienna (AT)

09:25 - 09:35

Con

J. Palou, Barcelona (ES)

09:35 - 09:45

Discussion

Moderators :

J.W.F. Catto, Sheffield (GB)

M. Rouprêt, Paris (FR)

A. Stenzl, Tübingen (DE)

Panel :

J. Palou, Barcelona (ES)

S. Shariat, Vienna (AT)

09:45 - 10:00

Immunotherapy and beyond: New options for NMIBC

P. Black, Vancouver (CA)

10:00 - 10:15

Urinary markers in low-grade NMIBC: Ready to stop cystoscopies?

J.A. Witjes, Nijmegen (NL)

10:15 - 10:30

Frailty and cognitive assessment in patients diagnosed with MIBC

G. Pignot, Marseille (FR)

10:30 - 10:45

Treatment options for elderly patients with muscle-invasive bladder cancer

M.J. Ribal Caparros, Barcelona (ES)

10:45 - 11:00

Different bladder cancer genotypes: New treatment options

R. Seiler, Bern (CH)

11:00 - 11:15

The future of personalised treatment: Test the tumour for a response

M. Shen, New York (US)

11:15 - 11:25

Discussion, questions and answers

J.W.F. Catto, Sheffield (GB)

M. Rouprêt, Paris (FR)

A. Stenzl, Tübingen (DE)

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

J.W.F. Catto, M. Rouprêt, A. Stenzl

Definition of very high-risk and refractory NMIBC

Inglês

 

Speakers

M. Babjuk, S. Shariat, J. Palou, P. Black, J.A. Witjes, G. Pignot, M.J. Ribal Caparros, R. Seiler, M. Shen

 

Link to the Event

Banner to the Event

#EAU20 Virtual - Challenges across the spectrum of bladder cancer